Diana Brixner
Overview
Explore the profile of Diana Brixner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daoud O, Gladstein J, Brixner D, OBrochta S, Naik S
Am J Manag Care
. 2025 Feb;
31(1 Suppl):S3-S12.
PMID: 39899753
The US HIV/AIDS Strategy and Ending the HIV Epidemic (EHE) initiatives aim to reduce HIV transmission by 90% by 2030 through targeted care and prevention initiatives such as the Undetectable ...
2.
Yang M, Mittal M, Fendrick A, Brixner D, Sherman B, Liu Y, et al.
Adv Ther
. 2024 Dec;
42(2):568-578.
PMID: 39704878
The healthcare system in the United States (US) is complex and often fragmented across national and regional health plans which exhibit substantial variability in benefit design and formulary policies for...
3.
Sullivan P, Brixner D, Lam J, Hsiao A
Am J Manag Care
. 2024 Dec;
30(11 Suppl):S207-S215.
PMID: 39652788
The HIV epidemic remains a critical public health priority in the United States. The Ending the HIV Epidemic (EHE) initiative seeks to reduce HIV diagnoses by 75% by 2025 and...
4.
Hejazi A, Willis C, Ye X, Youssef J, Moebus C, Goss B, et al.
Interv Pain Med
. 2024 Dec;
3(4):100522.
PMID: 39624774
Background Context: Patients with mechanical chronic lower back pain (CLBP) have few durable treatment options for their condition and thus suffer decreased productivity and have higher healthcare resource utilization (HRU)...
5.
Malone D, Biskupiak J, Brixner D, Oderda G, Seheult R
Am J Health Syst Pharm
. 2024 Oct;
PMID: 39475087
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are...
6.
Anderson K, Chaiyakunapruk N, Gutierrez E, Schmutz H, Rose M, Brixner D, et al.
Health Aff (Millwood)
. 2024 Aug;
43(8):1137-1146.
PMID: 39102598
Nearly all patients with type 1 diabetes and 20-30 percent of patients with type 2 diabetes use insulin to manage glycemic control. Approximately one-quarter of patients who use insulin report...
7.
Oderda G, Brixner D, Biskupiak J, Harnett J, Chen C, Quek R
J Manag Care Spec Pharm
. 2024 Aug;
30(8):825-833.
PMID: 39088340
Background: There is limited knowledge of how US managed care professionals view and prioritize quality metrics/performance measures, care models, alternative payment models, and clinical pathways in oncology settings. Objective: To...
8.
Tan C, Ilham S, Willis C, Kim A, Cong Z, Brixner D, et al.
Curr Med Res Opin
. 2024 Jul;
40(9):1577-1587.
PMID: 39082096
Objective: To assess the screening efficiency of an multi-cancer early detection (MCED) test added to standard of care (SoC) screening, compared to SoC screening alone, among immunocompromised individuals, and to...
9.
Willis C, Au T, Hejazi A, Griswold C, Schabath M, Thompson J, et al.
J Manag Care Spec Pharm
. 2024 Jul;
30(7):672-683.
PMID: 38950155
Background: Neurotrophic tyrosine receptor kinase () gene fusions are rare oncogenic drivers prevalent in 0.3% of solid tumors. They are most common in salivary gland cancer (2.6%), thyroid cancer (1.6%),...
10.
Chhibber A, Watanabe A, Jacobs H, Kharat A, Syeed S, Sherwin C, et al.
J Cyst Fibros
. 2024 Jun;
23(5):1010-1019.
PMID: 38937211
Background: With advancements in CF drug development, people with cystic fibrosis (PwCF) now take a median of seven medications daily, increasing treatment complexity, risk of drug therapy problems (DTPs), and...